Archive - March 2022
Gene team supports therapies for previously untreatable brain regions
Cell door: EMA grants ATMP classification to CELTIC-19
COVID: Risk Of Severe Disease Could Be In Your Blood, New Research Finds
Older Americans More At Risk Of Injury, Death From Consumer Products, Report Finds
Most Side Effects Of Pfizer, Moderna Vaccines Are Mild, Fade After One Day: Study
FDA approves BMS’ Opdivo with chemotherapy for certain lung cancer patients
bluebird bio shares therapy updates for 2022
Roche launches molecular system to increase diagnostic testing access